Abstract
Severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2) is an extremely pathogenic virus belonging to the family of Coronaviridae. First identified in Wuhan, China in December 2019 after an epidemiological investigation of an emerging cluster of pneumonia of unknown etiology, SARS-CoV-2 was declared the cause of a pandemic on March 11 by the World Health Organization (WHO), pointing to the over 118000 cases of Coronavirus disease 2019 (COVID-19) in over 110 countries. Despite the promising results of drug repositioning studies in the treatment of COVID-19, the evidence of their safety and efficacy remains inconclusive. Cell based therapy has been proven safe and possibly effective in treating multiple lung injuries and diseases, but its potential use in the treatment of COVID-19 has not been yet elucidated. Our aim in this review is to provide an overview of the immunomodulatory effect and the regenerative capacity of stem cells and their secretome in the treatment of many diseases including lung injuries. Those findings may contribute to a better understanding of the potential of stem cell therapy in SARS-CoV-2 infection and its potential use in order to find a solution for this healthcare crisis.
Keywords: Coronavirus, COVID-19, stem cells, cytokine storm, lung injuries, immunomodulatory effect.
Current Molecular Medicine
Title:Addressing the Importance of Stem Cell-Based Therapy: A Perspective in the Treatment of COVID-19
Volume: 21 Issue: 6
Author(s): Christine Ibrahim, Hanna Semaan, Marwan El-Sabban*, Fadia Najjar*Aline Hamade*
Affiliation:
- Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut,Lebanon
- Laboratoire d’Innovation Thérapeutique, Departments of Biology, Chemistry and Biochemistry, Lebanese University, Faculty of Sciences II, Fanar,Lebanon
- Laboratoire d’Innovation Thérapeutique, Departments of Biology, Chemistry and Biochemistry, Lebanese University, Faculty of Sciences II, Fanar,Lebanon
Keywords: Coronavirus, COVID-19, stem cells, cytokine storm, lung injuries, immunomodulatory effect.
Abstract: Severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2) is an extremely pathogenic virus belonging to the family of Coronaviridae. First identified in Wuhan, China in December 2019 after an epidemiological investigation of an emerging cluster of pneumonia of unknown etiology, SARS-CoV-2 was declared the cause of a pandemic on March 11 by the World Health Organization (WHO), pointing to the over 118000 cases of Coronavirus disease 2019 (COVID-19) in over 110 countries. Despite the promising results of drug repositioning studies in the treatment of COVID-19, the evidence of their safety and efficacy remains inconclusive. Cell based therapy has been proven safe and possibly effective in treating multiple lung injuries and diseases, but its potential use in the treatment of COVID-19 has not been yet elucidated. Our aim in this review is to provide an overview of the immunomodulatory effect and the regenerative capacity of stem cells and their secretome in the treatment of many diseases including lung injuries. Those findings may contribute to a better understanding of the potential of stem cell therapy in SARS-CoV-2 infection and its potential use in order to find a solution for this healthcare crisis.
Export Options
About this article
Cite this article as:
Ibrahim Christine , Semaan Hanna , El-Sabban Marwan *, Najjar Fadia *, Hamade Aline *, Addressing the Importance of Stem Cell-Based Therapy: A Perspective in the Treatment of COVID-19, Current Molecular Medicine 2021; 21 (6) . https://dx.doi.org/10.2174/1566524020999201117120147
DOI https://dx.doi.org/10.2174/1566524020999201117120147 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cellular and Molecular Mechanisms of Apoptosis in Age-Related Muscle Atrophy
Current Aging Science De-Risking Bio-therapeutics for Possible Drug Interactions Using Cryopreserved Human Hepatocytes
Current Drug Metabolism Advanced Oxidation Processes for the Removal of Food Dyes in Wastewater
Current Organic Chemistry Direct Vascular Targets For Atherosclerosis Prevention
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues
Current Pediatric Reviews Influence of Prebiotics on the Human Immune System (GALT)
Recent Patents on Inflammation & Allergy Drug Discovery Recombinant Human Polyclonal Antibodies: A New Class of Therapeutic Antibodies Against Viral Infections
Current Pharmaceutical Design Protective Growth Factors for Graft-Versus-Host Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Reduction of Doxorubicin-Induced Cardiotoxicity Using Nanocarriers: A Review
Current Drug Metabolism Influence of Two Cyclodextrin HP-derivatives on Retention and Migration Distance of Some Isomers in High- Performance Thin-Layer Chromatography and Pressurized Planar Electrochromatography Systems with Non-polar Adsorbents
Current Analytical Chemistry Surgical Treatment of Endometriosis
Current Women`s Health Reviews Perspectives of Fullerenes, Dendrimers, and Heterocyclic Compounds Application in Tumor Treatment
Recent Patents on Nanomedicine Therapeutic Modulation of Cytokines in Chronic Infectious Diseases
Current Pharmaceutical Design Aminooxy-Acetic Acid Inhibits Experimental Autoimmune Uveitis by Modulating the Balance between Effector and Regulatory Lymphocyte Subsets
Current Molecular Medicine L-DOPA Suppressed Scratching Behavior and Modified Brain Monoamine/ Amino Acid Concentrations in Mice
Letters in Drug Design & Discovery Melatonin Role in Experimental Arthritis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy
Current Molecular Pharmacology Muscarinic Acetylcholine Receptors: New Potential Therapeutic Targets in Antinociception and in Cancer Therapy
Recent Patents on CNS Drug Discovery (Discontinued) Severe Influenza: Clinical Features and Treatment Options
Current Respiratory Medicine Reviews Parkinson’s Disease: Is there a Role for Dietary and Herbal Supplements?
CNS & Neurological Disorders - Drug Targets